Joseph Mikhael, MD, talks about what attendees can expect from the myeloma session at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Dr Jabbour will be presenting on the management of patients with Ph+ and Ph-like ALL and taking part in a debate on approaches for the treatment of patients with relapsed ALL.
Dr Roboz gives attendees a taste of what's to come at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Agner Paner, MD, will address updates in supportive care for patients with multiple myeloma at the virtual 2020 Great Debates & Updates in Hematologic Malignancies.
Ruben Mesa, MD, FACP, explains current and emerging therapy options for patients with myeloproliferative neoplasms.
Keith Stewart, MD, ChB, discusses therapeutic approaches for patients with early relapse of MM.
Ruben Mesa, MD, FACP, provides an update on therapy options for the treatment of chronic idiopathic myelofibrosis.
Thomas Martin, MD, discusses the evolution of minimal residual disease testing in multiple myeloma and whether or not it is ready for prime time.